SCHEMBL7080256

SCHEMBL7080256

CCCC(=O)NS(=O)(=O)c1ccccc1NC(=O)c1ccccc1Oc1cccnc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.50
ALDH1A1 P00352 2/20 0.50
MAPK1 P28482 1/20 0.50
RAB9A P51151 2/20 0.45
MTNR1B P49286 1/20 0.41
MAPT P10636 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
SGMS2 Q8NHU3 1/20 0.41
TP53 P04637 1/20 0.41
HTT P42858 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
NPC1 O15118 1/20 0.41
GAA P10253 1/20 0.41
HPGD P15428 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
TSHR P16473 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7080331 0.86 SGMS2 (0.52) SGMS2RXFP1MEN1KMT2A
SCHEMBL7076729 0.83 MTNR1B (0.45) HSD17B10ALDH1A1RAB9AMTNR1BMAPT
SCHEMBL7080643 0.82 RAB9A (0.43) HSD17B10ALDH1A1MAPK1RAB9AMTNR1B
SCHEMBL7083369 0.82 RAB9A (0.43) HSD17B10ALDH1A1MAPK1RAB9AMTNR1B
SCHEMBL7083339 0.77 CAPN1 (0.46) MAPK1RAB9AMAPTSGMS2TP53
SCHEMBL7076725 0.75 MTNR1B (0.48) ALDH1A1RAB9AMTNR1BNPSR1TP53
SCHEMBL24292129 0.75 ALDH1A1 (0.54) HSD17B10ALDH1A1MAPK1RAB9ASGMS2
SCHEMBL7744231 0.74 CASP1 (0.51) MTNR1BNPSR1L3MBTL1POLBATM
SCHEMBL7081568 0.74 PTK2 (0.41) HSD17B10ALDH1A1MAPK1MAPTNPSR1
SCHEMBL7077440 0.74 MAPT (0.41) HSD17B10ALDH1A1MAPK1MAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030162818-A1 Acylsulfonamide derivative AJINOMOTO CO. INC. (JP) 2003-08-28 US disclosed
US-6555584-B1 Acetyl-coa carboxylase inhibitors AJINOMOTO CO., INC. (JP) 2003-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162818-A1 Acylsulfonamide derivative ACSS2, ACACA, FASN HSD17B10 43/4885ALDH1A1 385/4885MAPK1 1725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.